Compare USAS & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | USAS | LMAT |
|---|---|---|
| Founded | 1998 | 1983 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 2.6B |
| IPO Year | 2004 | 2006 |
| Metric | USAS | LMAT |
|---|---|---|
| Price | $6.09 | $113.01 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | $6.50 | ★ $105.80 |
| AVG Volume (30 Days) | ★ 5.3M | 178.4K |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.87% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | N/A | ★ 2.52 |
| Revenue | N/A | ★ $249,602,000.00 |
| Revenue This Year | $174.68 | $14.21 |
| Revenue Next Year | $53.17 | $8.88 |
| P/E Ratio | ★ N/A | $45.64 |
| Revenue Growth | N/A | ★ 13.53 |
| 52 Week Low | $0.55 | $78.01 |
| 52 Week High | $10.50 | $118.01 |
| Indicator | USAS | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 46.48 | 53.54 |
| Support Level | $4.71 | $81.60 |
| Resistance Level | $6.24 | $113.40 |
| Average True Range (ATR) | 0.42 | 2.85 |
| MACD | 0.17 | -0.33 |
| Stochastic Oscillator | 47.07 | 51.78 |
Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.